Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic CancerThierry Conroy, Jean François Seitz, James Biagi et al.|JAMA Oncology|2022Cited by 322
Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trialRené Adam, Céline Piedvache, L. Chiche et al.|The Lancet|2024Cited by 153
Safety and feasibility of chemotherapy followed by liver transplantation for patients with definitely unresectable colorectal liver metastases: insights from the TransMet randomised clinical trialRené Adam, M. Lewin, David Badrudin et al.|EClinicalMedicine|2024Cited by 34
Long-Term Therapy With Bevacizumab in a Patient With Glanzmann’s Thrombasthenia and Recurrent Digestive Bleeding due to Gastrointestinal Angiodysplastic LesionsRaphaël Marlu, Bruno Bonaz, Justine Barthelon et al.|The American Journal of Gastroenterology|2015Cited by 20